Active Incredients
Lidocaine 2%
Radx
FDA Label NDC 58133-650
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Cosmetic Specialty Labs, Inc. for the product Radx (NDC 58133-650). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active incredients, purpose, uses, warnings, otc - when using, otc - stop use, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Topical Anesthetic
Uses
- Provides immediate pain relief to skin undergoing radiation therapy
- Helps reduce inflammation
- Hydrates skin into the 2nd and 3rd dermal layers
- Helps Promote cell regeneration
Warnings
For external use only.
Otc - When Using
keep out of eyes. Rinse with water to remove.
Otc - Stop Use
Stop us and ask a doctor if rash occurs.
Otc - Keep Out Of Reach Of Children
Keep ouf of reach of children. If the product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply immediately following treatments, increasing to multiple times daily if skin becomes irritated, painful or inflamed.
- May be applied as frequently as once per hour.
Inactive Ingredients
Water, Cetearyl Olivate, Sorbitan Olivate, Helianthus Annuus (Sunflower) Seed Oil, Cocos Nucifera (Coconut) Oil, Cetyl Phosphate, Cetearyl Alcohol, Leuconostoc/Radish Root Ferment Filtrate, Hippophae Rhamnoides (Sea Buckthorn) Extract, Hydrogenated Ethylhelxyl Olivate, Hydrogenated Olive Oil Unsaponifiables, Carica Papaya (Papaya) Seed Oil, Beta-Glucan, C12-C15 Alkyl Benzoate, Tocopheryl Linoleate/Oleate, Sodium Hyaluronate, Allentoin, Aloe Barbadensis, Bromelain, Xanthan Gum, Hydrolyzed Silk
* Please review the disclaimer below.
